Loading organizations...
Tiba Biotech develops novel RNA medicines, with an initial focus on vaccines and subsequent expansion into high-impact therapeutics. The company integrates a proprietary, fully biodegradable nanoparticle delivery platform with advanced computational RNA design. This dual innovation aims to enhance the safety and potency of genetic expression.
Emerging from extensive government-sponsored research, Tiba Biotech was established to advance RNA technology. The foundational insight stemmed from recognizing limitations in existing RNA delivery, driving a pursuit of better patient outcomes through rational design. The company formed with a clear objective to transform therapeutic solutions.
Tiba Biotech's advanced RNA solutions are intended for broad application across critical health areas, encompassing early discovery in immuno-oncology and gene delivery. Collaborating with institutions like the NIH and BARDA, the company serves patients requiring next-generation vaccines and therapeutics. Its long-term vision is to unlock new therapeutic possibilities and significantly improve global health.
Tiba has raised $4.0M across 1 funding round.
Tiba has raised $4.0M in total across 1 funding round.
Direct answer: I found several different technology companies and organizations named “Tiba” (or “TIBA”) with distinct businesses — I need to know which one you want profiled (healthcare software, parking systems, RNA-delivery biotech, or IT services). Below I give a short, structured profile for each candidate so you can pick one for a deeper write-up.[1]
High‑Level overviews (concise)
Origin / backstory (brief for each)
Core differentiators (skimmable bullets)
Role in the broader tech landscape (short analysis)
Quick take & future outlook (what’s next)
Next step — pick which “Tiba / TIBA” above you want a full profile on (investment‑firm style or portfolio‑company style). I’ll then expand the chosen profile into the requested sections with citations and a cohesive narrative.
Tiba has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in February 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2022 | $4M Seed | — | 99 Startups, HI Ventures, Alpha4 Ventures, Astella, Canaan Partners, Canary Ventures, Coatue, FasterCapital, Global Founders Capital, Graph Ventures, Latitud, Monashees, Norte Ventures, Hans Tung, Picus Capital, Silence, Torch Capital, Xochi Ventures, Y Combinator, Anna Yuan, Ariel Lambrecht, David Vélez, Justin Mateen, Karim Atiyeh, Manolo Atala, Mauricio Feldman, Michael Levinthal, MIK Attisani, Nicky Goulimis, Oliver Jung, Philippe Teixeira DA Mota, Renato Freitas, Ricardo Weder, Sahin Boydas, Sergio Furio | Announced |
Tiba has raised $4.0M in total across 1 funding round.
Tiba's investors include 99 Startups, ALLVP, Alpha4 ventures, Astella, Canaan Partners, Canary Ventures, Coatue, FasterCapital, Global Founders Capital, Graph Ventures, Latitud, monashees.